WellDoc®’s Digital Health and Diabetes Thought Leadership Team to Present at Upcoming Industry Conferences

WellDoc®’s Digital Health and Diabetes Thought Leadership Team to Present at Upcoming Industry Conferences

March 21, 2017

Columbia, Maryland, March 21, 2017 – Digital health technology leader, WellDoc®,  announced today its involvement in several key conferences and industry events over  the next few months with various company thought leaders set to speak and/or  participate in panel discussions. The list of events is as follows:

2017 BioHealth Capital Region Forum
April 19 – 20, 2017, MedImmune, Gaithersburg, MD
WellDoc CEO Kevin McRaith will participate in the “Advancing Science” panel at 10:50 a.m. ET on April 20

Academy of Managed Care Pharmacists (AMCP) Annual Meeting 2017
March 27 – 30, 2017, Colorado Convention Center, Denver, CO
WellDoc Vice President of Clinical Advocacy Malinda Peeples, RN, MS,  CDE, will present “The Basics of Mobile Health (mHealth) and its Potential Impact” at 8:30 a.m. MT on March 30

Mid-Atlantic Telehealth Resource Center 2017 Telehealth Summit
April 2 – 4, 2017, Lansdowne Resort, Leesburg, VA
Ms. Peeples will participate in the panel discussion, “Digital Health: Innovations in Population Health and Health Service Delivery,” at 2:15 p.m. ET on April 3

American Telemedicine Association (ATA) 2017: Telehealth 2.0
April 23 – 25, 2017, Orange County Convention Center, Orlando, FL
Ms. Peeples will present with the Senior Business Lead at Ontario Telemedicine Network (OTN) on “Developing a Clinical Model for Mobile Health Integration in Ontario,” at 3:00 p.m. ET on April 23

5th Annual Medical Informatics World Conference
May 22 – 23, 2017, Renaissance Waterfront Hotel, Boston, MA
Ms. Peeples will present “Digital Health: Connecting Patients and the Healthcare Team to Deliver Clinical Outcomes” at 11:50 a.m. ET on May 23

About WellDoc®

WellDoc is a digital health technology company that develops mobile solutions to drive behavioral and clinical change in chronic disease. WellDoc’s goal is to improve patient self-management and help physicians overcome gaps in the delivery system to improve clinical outcomes and decrease cost. WellDoc has commercialized BlueStar®, a digital therapeutic, for adults with type 2 diabetes. This therapeutic is designed to fill the support gap between patients and providers during the 8700 hours that individuals live their lives outside the healthcare system each year. WellDoc has a proven track record of contributing published, peer-reviewed clinical evidence since 2008 and presented real-world patient engagement and clinical outcomes at the American Diabetes  Association’s (ADA) 76th Scientific Sessions. BlueStar® is recognized by the ADA on its website as the first and only in the new class of diabetes treatment known as Mobile Prescription Therapy. In a recently published Forbes blog, WellDoc was named among one of five healthcare tech companies to watch in 2016. For more information, visit www.WellDoc.com and www.BlueStarDiabetes.com.

Register for our webinar with the American Telemedicine Association
Connecting the Dots in Chronic Care: How Data Insights Transform the Patient Experience